Emerging data highlights the potential of metabolic hormones and co-agonist approaches to revolutionize our grasp of cellular communication. These miniature peptides, often functioning as potent regulatory mimics, offer a unique avenue to simultaneously adjust multiple receptors, surpassing the limitations of traditional single therapeutic agents.